SEC 13F Intelligence

Jennison Associates LLC / VRTX

Jennison Associates LLC’s Vertex Pharmaceuticals Inc Position

Does Jennison Associates LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 2.74M shares worth $1.2B (+0.84% of its 13F portfolio) as of Q1 2026, down from 3.25M shares the prior filed quarter.

Position Value
$1.2B
Q1 2026
Shares
2.74M
% of Portfolio
+0.84%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.2BQ3 ’19: $1.0BQ4 ’19: $782MQ4 ’19Q1 ’20: $1.0BQ2 ’20: $1.3BQ3 ’20: $982MQ4 ’20: $886MQ4 ’20Q1 ’21: $154MQ2 ’21: $160MQ3 ’21: $150MQ4 ’21: $172MQ4 ’21Q1 ’22: $91MQ2 ’22: $499MQ3 ’22: $1.4BQ4 ’22: $1.5BQ4 ’22Q1 ’23: $1.4BQ2 ’23: $1.3BQ3 ’23: $1.3BQ4 ’23: $1.6BQ4 ’23Q1 ’24: $2.0BQ2 ’24: $2.2BQ3 ’24: $2.6BQ4 ’24: $1.7BQ4 ’24Q1 ’25: $2.5BQ2 ’25: $2.7BQ3 ’25: $1.4BQ4 ’25: $1.5BQ4 ’25Q1 ’26: $1.2Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.74M$1.2B+0.84%
Q4 20253.25M$1.5B+0.88%
Q3 20253.45M$1.4B+0.79%
Q2 20256.15M$2.7B+1.62%
Q1 20255.06M$2.5B+1.72%
Q4 20244.32M$1.7B+1.06%
Q3 20245.55M$2.6B+1.60%
Q2 20244.70M$2.2B+1.41%
Q1 20244.78M$2.0B+1.34%
Q4 20233.94M$1.6B+1.20%
Q3 20233.80M$1.3B+1.12%
Q2 20233.81M$1.3B+1.10%
Q1 20234.58M$1.4B+1.32%
Q4 20225.12M$1.5B+1.50%
Q3 20224.76M$1.4B+1.37%
Q2 20221.77M$499M+0.50%
Q1 2022350.1K$91M+0.07%
Q4 2021783.4K$172M+0.11%
Q3 2021829.4K$150M+0.10%
Q2 2021791.8K$160M+0.11%
Q1 2021715.8K$154M+0.11%
Q4 20203.75M$886M+0.63%
Q3 20203.61M$982M+0.79%
Q2 20204.42M$1.3B+1.16%
Q1 20204.36M$1.0B+1.26%
Q4 20193.57M$782M+0.79%
Q3 20195.98M$1.0B+1.07%
Q2 20196.34M$1.2B+1.15%
Q1 20196.80M$1.3B+1.24%
Q4 20186.94M$1.2B+1.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jennison Associates LLC’s full portfolio or all institutional holders of VRTX.